Sneha Tilak

Sneha Tilak practices at Dignity Health Advanced Imaging - Elk Grove in Elk Grove, California.

Sneha Tilak's NPI, 1184943367, was assigned on May 27, 2010. Sneha Tilak holds California license PA20610.

Sneha Tilak's primary practice is Dignity Health Advanced Imaging - Elk Grove, at 8220 Wymark Dr. Suite 101, Elk Grove, CA 95757. The practice phone is (916) 464-7600.

Sneha Tilak's primary practice is Dignity Health Advanced Imaging - Elk Grove in Elk Grove, California. Sneha Tilak is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Sneha Tilak to 1 more physician office and 1 group practice or clinic, each named with a free account. Sneha Tilak's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Sneha Tilak practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Sneha Tilak's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sneha Tilak is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sneha Tilak is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, scalp rash, skin cyst and skin discoloration among the conditions Sneha Tilak treats.

CMS data shows 1,285 Medicare services from Sneha Tilak across 8 procedure codes in 2024, for 362 Medicare patients. Medicare paid $56,941 for them. Every service was in an office.

CMS counts 362 Medicare patients who saw Sneha Tilak in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sneha Tilak's median patient age at 53, with 62% women.

In 2024, Sneha Tilak wrote 1,327 Medicare Part D claims for 417 patients. 96% of them were for generic drugs. CMS names the drug for 1,173 of them, across 24 drugs with 11 or more claims each, at $183,629 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Sneha Tilak for performance year 2024, reported through an alternative payment model (APM). Sneha Tilak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sneha Tilak from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $133.